This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...
Scientists developed a highly promising gene therapy to treat glaucoma -- a debilitating eye condition that can lead to complete vision loss, and which affects around 80 million people worldwide. The ...
With most cases of glaucoma, a buildup of fluid causes pressure within the eye. As that pressure increases, it affects the optic nerve at the back of the eye. “Basically, you kind of see peripheral ...
Combination therapy seeks to improve intraocular pressure lowering by pairing a novel EVP-targeting agent with prostaglandin analogue standard of care DEDHAM, Mass.--(BUSINESS WIRE)--Qlaris Bio, Inc., ...
Please provide your email address to receive an email when new articles are posted on . Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and ...
Iridex Corporation announced the publication of a significant peer-reviewed study in Ophthalmology Therapy, demonstrating the long-term safety and efficacy of MicroPulse Transscleral Laser Therapy ...
Myra Vision has enrolled the first patient in the ADAPT clinical trial assessing its Calibreye Titratable Glaucoma Therapy (TGT) surgical system in the US, following recent approval of its ...
VILNIUS, LT / ACCESS Newswire / July 29, 2025 / Diorasis Therapeutics (“DTx”), a preclinical-stage biotechnology company developing gene therapies for ophthalmic diseases, has entered into a strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results